Skip to content

Author

P. Gilsanz

We have 5 of 266 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Role of APOE ɛ4 and ɛ2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study.

BACKGROUND AND OBJECTIVES APOE ɛ4 is the strongest genetic risk factor for late-onset Alzheimer disease, while ɛ2 is associated with decreased risk. However, it is unclear how these genotypes relate to cognitive decline among those aged older than 90+. We examined associations of ɛ4 and ɛ2 with longitudinal change in 3...

H. Colbeth, A. Posis, Batool Rizvi et al. · 0 citations
Review Aug 2026

Hypertension and 10-Year Dementia Risk Among Older Asian American and Non-Latino White Adults in Northern California.

INTRODUCTION Hypertension is a modifiable risk factor for dementia, but its contribution among Asian American ethnic groups remains understudied despite heterogeneity in cardiovascular risk factors. METHODS Participants were Kaiser Permanente Northern California members aged 60 to 90 years without prevalent dementia...

L. P. Rojas-Saunero, Natalie M Gradwohl, J. Fong et al. · 0 citations
Sep 2026

Gait Speed and Survival in Those With Exceptional Longevity: The LifeAfter90 Study.

BACKGROUND Although gait speed is a well-established predictor of mortality, it is understudied among ethnoracially diverse oldest-old cohorts. We examined the association between gait speed and all-cause mortality in an ethnoracially diverse 90+ population. METHODS We examined the association between gait speed and...

Rifat B. Alam, Hilary L. Colbeth, A. Posis et al. · 0 citations
Open access Aug 2026

Beyond amyloid: Contributions of neuroinflammation, cerebrovascular disease, and neurodegeneration to memory impairment in the oldest‐old, the LifeAfter90 Study

It is hypothesized that elevated neuroinflammation, indicated by reactive astrocytosis, acts on cerebrovascular disease and separately, on amyloid beta (Aβ) pathology, to promote downstream medial temporal lobe atrophy and memory impairment.

Batool M. Rizvi, P. Maillard, A. Posis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.